# Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

> **NCT00906204** · PHASE2 · COMPLETED · sponsor: **Wright State University** · enrollment: 99 (actual)

## Conditions studied

- End-Stage Renal Disease
- Kidney Failure

## Interventions

- **BIOLOGICAL:** Single-dose rabbit Anti-thymocyte Globulin induction
- **BIOLOGICAL:** Divided-dose rabbit Anti-thymocyte Globulin induction

## Key facts

- **NCT ID:** NCT00906204
- **Lead sponsor:** Wright State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2015-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906204, "Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00906204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*